74 related articles for article (PubMed ID: 23775081)
41. Mechanisms of neurotransmitter release by amphetamines: a review.
Sulzer D; Sonders MS; Poulsen NW; Galli A
Prog Neurobiol; 2005 Apr; 75(6):406-33. PubMed ID: 15955613
[TBL] [Abstract][Full Text] [Related]
42. Addiction research in a simple animal model: the nematode Caenorhabditis elegans.
Schafer WR
Neuropharmacology; 2004; 47 Suppl 1():123-31. PubMed ID: 15464131
[TBL] [Abstract][Full Text] [Related]
43. Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine.
Budygin EA; Brodie MS; Sotnikova TD; Mateo Y; John CE; Cyr M; Gainetdinov RR; Jones SR
Proc Natl Acad Sci U S A; 2004 May; 101(20):7781-6. PubMed ID: 15136721
[TBL] [Abstract][Full Text] [Related]
44. LIM homeobox gene-dependent expression of biogenic amine receptors in restricted regions of the C. elegans nervous system.
Tsalik EL; Niacaris T; Wenick AS; Pau K; Avery L; Hobert O
Dev Biol; 2003 Nov; 263(1):81-102. PubMed ID: 14568548
[TBL] [Abstract][Full Text] [Related]
45. Individual differences in cocaine-induced locomotor sensitization in low and high cocaine locomotor-responding rats are associated with differential inhibition of dopamine clearance in nucleus accumbens.
Sabeti J; Gerhardt GA; Zahniser NR
J Pharmacol Exp Ther; 2003 Apr; 305(1):180-90. PubMed ID: 12649367
[TBL] [Abstract][Full Text] [Related]
46. Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative.
Zhou FC; Lesch KP; Murphy DL
Brain Res; 2002 Jun; 942(1-2):109-19. PubMed ID: 12031859
[TBL] [Abstract][Full Text] [Related]
47. Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates.
Drouin C; Darracq L; Trovero F; Blanc G; Glowinski J; Cotecchia S; Tassin JP
J Neurosci; 2002 Apr; 22(7):2873-84. PubMed ID: 11923452
[TBL] [Abstract][Full Text] [Related]
48. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.
Bunzow JR; Sonders MS; Arttamangkul S; Harrison LM; Zhang G; Quigley DI; Darland T; Suchland KL; Pasumamula S; Kennedy JL; Olson SB; Magenis RE; Amara SG; Grandy DK
Mol Pharmacol; 2001 Dec; 60(6):1181-8. PubMed ID: 11723224
[TBL] [Abstract][Full Text] [Related]
49. Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene.
Carboni E; Spielewoy C; Vacca C; Nosten-Bertrand M; Giros B; Di Chiara G
J Neurosci; 2001 May; 21(9):RC141: 1-4. PubMed ID: 11312315
[TBL] [Abstract][Full Text] [Related]
50. C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway.
Sawin ER; Ranganathan R; Horvitz HR
Neuron; 2000 Jun; 26(3):619-31. PubMed ID: 10896158
[TBL] [Abstract][Full Text] [Related]
51. Correlation between behavior and extracellular dopamine levels in rat striatum: comparison of microdialysis and fast-scan cyclic voltammetry.
Budygin EA; Kilpatrick MR; Gainetdinov RR; Wightman RM
Neurosci Lett; 2000 Mar; 281(1):9-12. PubMed ID: 10686403
[TBL] [Abstract][Full Text] [Related]
52. In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors.
Zahniser NR; Larson GA; Gerhardt GA
J Pharmacol Exp Ther; 1999 Apr; 289(1):266-77. PubMed ID: 10087014
[TBL] [Abstract][Full Text] [Related]
53. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.
Gainetdinov RR; Wetsel WC; Jones SR; Levin ED; Jaber M; Caron MG
Science; 1999 Jan; 283(5400):397-401. PubMed ID: 9888856
[TBL] [Abstract][Full Text] [Related]
54. Neurotransmitter transporters as molecular targets for addictive drugs.
Amara SG; Sonders MS
Drug Alcohol Depend; 1998; 51(1-2):87-96. PubMed ID: 9716932
[TBL] [Abstract][Full Text] [Related]
55. Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine.
Darracq L; Blanc G; Glowinski J; Tassin JP
J Neurosci; 1998 Apr; 18(7):2729-39. PubMed ID: 9502830
[TBL] [Abstract][Full Text] [Related]
56. Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection.
Blanc G; Trovero F; Vezina P; Hervé D; Godeheu AM; Glowinski J; Tassin JP
Eur J Neurosci; 1994 Mar; 6(3):293-8. PubMed ID: 7912614
[TBL] [Abstract][Full Text] [Related]
57. The genetics of Caenorhabditis elegans.
Brenner S
Genetics; 1974 May; 77(1):71-94. PubMed ID: 4366476
[TBL] [Abstract][Full Text] [Related]
58. Cocaine self-administration appears to be mediated by dopamine uptake inhibition.
Ritz MC; Lamb RJ; Goldberg SR; Kuhar MJ
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):233-9. PubMed ID: 3387585
[TBL] [Abstract][Full Text] [Related]
59. Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat.
Dickinson SL; Gadie B; Tulloch IF
Psychopharmacology (Berl); 1988; 96(4):521-7. PubMed ID: 2907662
[TBL] [Abstract][Full Text] [Related]
60. Cocaine receptors on dopamine transporters are related to self-administration of cocaine.
Ritz MC; Lamb RJ; Goldberg SR; Kuhar MJ
Science; 1987 Sep; 237(4819):1219-23. PubMed ID: 2820058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
